Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transcription factor E2F binds DNA as a heterodimer

H E Huber1, G Edwards, P J Goodhart

  • 1Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486.

Proceedings of the National Academy of Sciences of the United States of America
|April 15, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synchronous renal malignancy presenting as recurrent urinary tract infections.

Case reports in urology·2012
Same author

Multiple pathways in the oxidation of cis-stilbene by iron-bleomycin.

Journal of the American Chemical Society·2012
Same author

Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer.

Prostate cancer and prostatic diseases·2002
Same author

Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.

Cancer research·2001
Same author

The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.

Journal of medicinal chemistry·2001
Same author

Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency.

Journal of medicinal chemistry·2001
Same journal

Chemotactic self-organization captures the dynamics of mammalian hair follicle patterning.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Tomographic imaging of superconducting order using particle-hole interference.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Improving cell-free metabolism through direct integration of artificial respiratory chains.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles

The transcription factor E2F, crucial for cell cycle control, functions as a complex. Reconstituting purified E2F components dramatically restored DNA binding activity, revealing its oligomeric nature.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • E2F is a mammalian transcription factor vital for cell cycle control.
  • Purified E2F from HeLa cells shows multiple protein bands on SDS-PAGE, suggesting a complex structure.

Purpose of the Study:

  • To investigate the subunit composition and DNA binding activity of the E2F transcription factor.
  • To determine if E2F functions as a monomer or a multimeric complex.

Main Methods:

  • DNA affinity chromatography to purify E2F from HeLa cells.
  • SDS-PAGE to separate protein components.
  • Electrophoretic purification, electroelution, and refolding of individual proteins.
  • Reconstitution experiments by mixing purified components.

Related Experiment Videos

  • Western blot analysis to compare with RBP3/E2F-1.

    • Main Results:

    • Individual E2F protein components exhibited poor DNA binding activity.
    • Mixing components resulted in a 100- to 1000-fold increase in specific DNA binding.
    • Optimal activity required a heterodimer of proteins from larger (approx. 60 kDa) and smaller (approx. 50 kDa) molecular mass groups.
    • The reconstituted heterodimer matched authentic E2F in DNA-binding specificity, DNA pattern, and retinoblastoma gene product binding.
    • RBP3/E2F-1 is related to the larger molecular mass E2F components.

    Conclusions:

    • E2F functions as an oligomeric complex, likely a heterodimer, composed of at least two distinct proteins.
    • The reconstitution of E2F activity from individual components highlights the importance of complex formation for DNA binding.
    • These findings contribute to understanding the mechanism of E2F-mediated gene regulation in cell cycle control.